Markets:

Overview

News

Currencies

International

Treasuries

DaVita HealthCare Partner (NY:DVA)

176.18 -1.09 (-0.61%)

Streaming Delayed Price Updated: 3:00 PM EDT, Aug 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

DaVita Inc (NYSE:DVA) Reports Mixed Q2 2025 Earnings with EPS Beat and Slight Revenue Miss ↗

August 05, 2025

DaVita Inc (NYSE:DVA) reported mixed Q2 2025 earnings, with revenue slightly missing estimates at $3.38B but EPS beating at $2.95. Stock rose modestly post-release.

Via Chartmill

Warren Buffett Just Bought Even More of This Dirt-Cheap Stock ↗

August 05, 2025

Berkshire Hathaway now owns 37% of this company.

Via The Motley Fool

Topics Regulatory Compliance

Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings ↗

August 05, 2025

Berkshire Hathaway sold 1.64 million shares of DaVita Inc. for $230 million just before DaVita's Q2 earnings.

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Warren Buffett's Berkshire Hathaway Offloads $230M Of This Dialysis Service Provider Ahead Of Its Q2 Earnings ↗

August 05, 2025

Analysts expect a strong Q2 for DaVita, with projected year-over-year growth in revenue, EBITDA, and earnings.

Via Stocktwits

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

DaVita (DVA) To Report Earnings Tomorrow: Here Is What To Expect

August 03, 2025

Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting results this Tuesday after market hours. Here’s what to look for.

Via StockStory

Topics World Trade

3 Healthcare Stocks We Approach with Caution

July 24, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Wednesday's session: top gainers and losers in the S&P500 index ↗

July 09, 2025

Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Explore the top gainers and losers within the S&P500 index in today's session. ↗

July 09, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug ↗

June 23, 2025

CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug.

Via Investor's Business Daily

Winners And Losers Of Q1: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks

June 11, 2025

Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q1 outpatient & specialty care earnings season.

Via StockStory

Topics Artificial Intelligence

1 Profitable Stock Worth Your Attention and 2 to Approach with Caution

June 05, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

DVA Q1 Earnings Call: Cyber Incident, Volume Decline, and Policy Updates Shape Outlook

June 04, 2025

Dialysis provider DaVita Inc. (NYSE:DVA) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 5% year on year to $3.22 billion. Its non-GAAP EPS of $2 per share was 1% below...

Via StockStory

3 Value Stocks with Questionable Fundamentals

May 28, 2025

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...

Via StockStory

Topics Economy

3 S&P 500 Stocks Walking a Fine Line

May 26, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Economy Stocks

Buffett Bought More of This High-Yield Dividend Stock in Q1. Should You Buy It, Too? ↗

May 22, 2025

Via The Motley Fool

Made in the USA: Warren Buffett Sells Out of 1 International Stock and Doubles His Stake in 2 U.S. Companies ↗

May 20, 2025

Via The Motley Fool

Buffett's Latest Portfolio Moves, and Another Secret Stock

May 19, 2025

Buffett's latest 13F shows no new positions in publicly traded companies, but includes a confidential mystery stake, sparking significant speculation.

Via MarketBeat

Topics Regulatory Compliance

Gapping S&P500 stocks in Monday's session ↗

May 19, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Warren Buffett Just Sold These 8 Stocks, One of Which Remains a Phenomenal Bargain (and a Top Holding of Mine) ↗

May 18, 2025

The Oracle of Omaha has been a big-time seller of stocks for 10 consecutive quarters -- but there's one sale he may regret.

Via The Motley Fool

Topics Regulatory Compliance

Warren Buffett Ditches Bitcoin-Linked Nu Holdings, Adds To Constellation Brands, Domino's Pizza, Pool Corp Stakes ↗

May 15, 2025

As legendary investor Warren Buffett prepares to step down as CEO of Berkshire Hathaway Inc.

Via Benzinga

These S&P500 stocks have an unusual volume in today's session ↗

May 13, 2025

In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

May 13, 2025

Stay tuned for the market movements in the S&P500 index on Tuesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

DaVita (NYSE:DVA) Beats Q1 Sales Targets

May 12, 2025

Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q1 CY2025, with sales up 5% year on year to $3.22 billion. Its non-GAAP profit of $2 per share was 1% below analysts’...

Via StockStory

US Stock Futures Rise As US, China Agree To 90-Day Tariff Pause: 'Wider Earnings Growth Should Drive More Balanced Market Performance,' Says Expert ↗

May 12, 2025

U.S. stock futures jumped on Monday after a muted day of trade on Friday. Futures of benchmark indices were trading over 2% in premarket.

Via Benzinga

Dow Falls Over 100 Points, Also Records Weekly Loss: Fear & Greed Index Remains In 'Greed' Zone ↗

May 12, 2025

Via Benzinga

Topics Stocks

Fox, NRG Energy And 3 Stocks To Watch Heading Into Monday ↗

May 12, 2025

Via Benzinga

Dow Futures Rally Over 400 Points As US, China 'Come To Agreement' In Geneva Trade Talks ↗

May 11, 2025

U.S. stock futures rose Sunday evening after weekend trade talks in Geneva signaled potential de-escalation in the ongoing trade war with China.

Via Benzinga

Topics Stocks World Trade

DaVita (DVA) Reports Earnings Tomorrow: What To Expect

May 11, 2025

Dialysis provider DaVita Inc. (NYSE:DVA) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.